1
TÍTULO: Bortezomib, melphalan, and prednisone with or without daratumumab in transplant-ineligible patients with newly diagnosed multiple myeloma (ALCYONE): final analysis of an open-label, randomised, multicentre, phase 3 trial  Full Text
AUTORES: Mateos, Maria Victoria; San Miguel, Jesus; Cavo, Michele; Suzuki, Kenshi; Jakubowiak, Andrzej; Knop, Stefan; Doyen, Chantal; Lucio, Paulo; Nagy, Zsolt; Pour, Ludek; Grosicki, Sebastian; Crepaldi, Andre; Liberati, Anna Marina; Campbell, Philip; Yoon, Sung Soo; Iosava, Genadi; Fujisaki, Tomoaki; Garg, Mamta; Ngo, Mai; Katz, Eva G.; Krevvata, Maria; Bolyard, Kasey; Carson, Robin; Borgsten, Fredrik; Dimopoulos, Meletios; ...Mais
PUBLICAÇÃO: 2025, FONTE: LANCET ONCOLOGY, VOLUME: 26, NÚMERO: 5
INDEXADO EM: Scopus WOS